Josephine Harrington, MD
Basic profileAdvanced Heart Failure and Transplant Cardiology
Josephine Harrington is a Cardiology physician. OpenAlex indexes 131 publications with 2,141 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12605 E 16th Ave
Aurora, CO 800452545
Telephone
720-848-0000Provider last certified this registry record 19 Jul 2024.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202513 payments$42,375openpaymentsdata.cms.gov ↗
- Novo Nordisk ASProgram year20256 payments$28,301openpaymentsdata.cms.gov ↗
- Bayer Healthcare Pharmaceuticals Inc.Program year202515 payments$24,529openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
56.6%GLP-1 receptor agonist41.9%Ozempic80%Mounjaro20%Part D<11 patientsSGLT2 inhibitor14.7%Jardiance100%Part D<11 patientsCardiovascular
43.4%Calcium channel blocker17.8%Amlodipine Besylate100%Part D<11 patientsStatin14%Rosuvastatin Calcium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 2025 ACC Scientific Statement on the Management of Obesity in Adults With Heart Failure
Journal of the American College of Cardiology
2025 - Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease
Journal of the American College of Cardiology
2025 - Advances in the management of obesity and heart failure: latest evidence from clinical trials
Current Opinion in Cardiology
2025 - Heart failure with preserved ejection fraction therapeutics: in search of the pillars
Heart Failure Reviews
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”